Antibodies

A modern immunotherapy approach to restore the main symptoms of cat allergy

How long do COVID-19 antibodies last?

Mutation of SARS-CoV-2 N501Y adversely affects cellular immune response

The Emory MVA COVID-19 vaccine has been proven safe and effective in mice and monkeys

A Phase 1 clinical trial of a new HIV vaccination approach is showing promising results

The Pfizer-BioNTech vaccine shows promise against new SARS-CoV-2 modifications

SARS-CoV-2 infectious disease follows specific antibody, T-cell responses

case study in distribution

Indoor single-dose vaccination produces antibodies and prevents infection in rhesus macaques

India’s Covaxin vaccine is likely to be effective against the UK SARS-CoV-2 variant: A study